This product is an ASHP Learning Center activity.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This self-paced, online professional certificate track is designed for pharmacists interested in expanding their knowledge and skills in human immunodeficiency virus (HIV).
Overview
The Specialty Pharmacy Certificate is self-guided, with online learning activities that have been created for pharmacists and pharmacy technicians seeking to expand their skills in specialty pharmacy.
A learner will have completed the Specialty Pharmacy Fundamentals before beginning the HIV Track.
The learner will take a deep dive into their selected specialty focus with the HIV Track. These topics include HIV treatments, HIV treatment management, drug interactions, opportunistic infections, HIV prevention, and HIV regimens in unique populations.
Professional Certificate Requiremen
Once a learner has completed the Specialty Pharmacy Fundamentals and the HIV track educational curriculum, they will have the opportunity to complete the track final exam. Once the learner successfully completes the track final exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the professional certificate.
Educational Activitie
Introduction to Human Immunodeficiency Virus (HIV)
ACPE: 0204-0000-23-829-H02-P
Application-based
1.5 contact hours
Learning Objectives:
- Differentiate human immunodeficiency virus (HIV) from acquired immunodeficiency syndrome (AIDS).
- Describe the pathophysiology of HIV.
- Identify risk factors for HIV transmission.
- Interpret the results of different generations of HIV diagnostic tests.
- Choose which laboratory assays should be utilized to monitor patients living with HIV.
- Summarize the effects of AIDS on the immune system.
HIV Treatment Introduction
ACPE: 0204-0000-23-830-H02-P
Application-based
1 contact hour
Learning Objectives:
- Describe the HIV life cycle.
- Compare the classes of antiretrovirals and their mechanisms of action.
- Identify the medications within each class of antiretrovirals.
- Use abbreviations for commonly used antiretrovirals.
- Differentiate tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF).
HIV Treatment Management
ACPE: 0204-0000-23-831-H02-P
Application-based
1.5 contact hours
Learning Objectives:
- Identify first-line treatment options for treatment-naïve and treatment-experienced patients living with HIV.
- Summarize the literature supporting use of reduced pill burden regimens.
- Explain the literature supporting the utilization of currently available long-acting injectable antiretrovirals.
- Interpret the most common HIV resistance mutations for their clinical implications.
- Evaluate patient specific factors that impact the choice of antiretroviral regimens.
- Create an appropriate treatment regimen for patients living with HIV, based on patient-specific characteristics and treatment history.
Drug Interactions
ACPE: 0204-0000-23-832-H02-P
Application-based
2 contact hours
Learning Objectives:
- Describe the synergistic, additive, and antagonistic types of drug interactions.
- Identify common drug interactions for each class of HIV antiretroviral medications.
- Recommend the action(s) needed for a drug interaction.
Opportunistic Infections
ACPE: 0204-0000-23-833-H02-P
Application-based
1 contact hour
Learning Objectives:
- Recommend when to initiate prophylaxis against opportunistic infections (OI).
- Choose which pharmacotherapy option(s) should be utilized dependent on the OI.
- Identify when OI prophylaxis can be stopped.
HIV Prevention
ACPE: 0204-0000-23-834-H02-P
Application-based
1.5 contact hours
Learning Objectives:
- Assess the HIV prevention needs within the United States.
- Differentiate HIV PEP from HIV PrEP.
- Identify appropriate candidates for HIV PEP.
- Identify appropriate monitoring parameters for patients who receive HIV PEP.
- Identify appropriate candidates for HIV PrEP.
- Identify appropriate monitoring parameters for patients who receive HIV PrEP.
HIV Regimens in Unique Populations
ACPE: 0204-0000-23-835-H02-P
Application-based
1.5 contact hours
Learning Objectives:
- Differentiate HIV infection rates for certain populations/groups of people in the United States.
- Identify ART regimens appropriate for each population.
- Recognize barriers to HIV care and ART adherence that certain populations may face.
- Recommend strategies for ART adherence and retention in care for each population.
Faculty Information
Amanda Binkley, PharmD, AAHIVP, BCIDP
Clinical Pharmacy Specialist Infectious Diseases
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Paul Djuricich, PharmD, AAHIVP
Clinical Pharmacy Specialist
University of Chicago Medicine
Chicago, Illinois
Carly Cloud Floyd, PharmD, PhC, AAHIVP, CDCES, TTS
Assistant Professor
Dept. of Pharmacy Practice and Admin. Sciences
University of New Mexico, College of Pharmacy
Clinical Director
University of New Mexico AIDS Education & Training Center (UNM-AETC)
Albuquerque, New Mexico
Ryan Kates, PharmD, BCACP, AAHIVP
Clinical Pharmacist
Northwestern Medicine
Chicago, Illinois
Relevant Financial Relationship Disclosure
In accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity's content have relevant financial relationships:
- Amanda Binkley: Viiv Healthcare, advisory panel
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Methods and CE Requirements
This online activity consists of a combined total of 7 learning modules. Pharmacists are eligible to receive a total of 10 hours of continuing education credit by completing all 7 modules within this professional certificate track.
Participants must participate in the entire activity and complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts to claim credit and view your statement of credit within 60 days of completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
System Technical Requirements
System requirements courses and learning activities are delivered via your web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for learning activities.